10,000 results
·
45ms
·
Sources: EU EUDAMED, US FDA
IMX(R) TOXO IGM
FDA 510(k)
FDA Class 2
·Microbiology
IMX FREE T4 CALCULATION
FDA 510(k)
FDA Class 2
·Clinical Chemistry
IMX CA 15-3
FDA 510(k)
FDA Class 2
·Immunology
ABBOTT IMX PROLACTIN(MODIFICATION)
FDA 510(k)
FDA Class 1
·Clinical Chemistry
MODIFICATION TO IMX HOMOCYSTEINE
FDA 510(k)
FDA Class 2
·Clinical Chemistry
IMX TOTAL B-HCG
FDA 510(k)
FDA Class 2
·Clinical Chemistry
ABBOTT IMX 2 ANALYZER
FDA 510(k)
FDA Class 1
·Clinical Chemistry
ABBOTT IMX FREE T4
FDA 510(k)
FDA Class 2
·Clinical Chemistry
IMX(R) GLYCATED HEMOGLOBIN
FDA 510(k)
FDA Class 2
·Hematology
IMX TOTAL B-HCG
FDA 510(k)
FDA Class 2
·Clinical Chemistry
IMX ULTRASENSISTIVE HTSH II
FDA 510(k)
FDA Class 2
·Clinical Chemistry
Hepatitis A Test (Antibody And Igm Antibody)
FDA Pre-Market Approval
FDA Class 2
·IMX HAVAB -M (LIST NUMBER 2263)
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
FDA Pre-Market Approval
FDA Class 2
·IMX AND AXSYM PSA
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·ABBOTT IMX AFP ASSAY
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·ABBOTT IMX FREE PSA
Enzyme Immunoassay, Tracrolimus
FDA Pre-Market Approval
FDA Class 2
·IMX TACROLIMUS II ASSAY
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
FDA Pre-Market Approval
FDA Class 2
·ABBOTT IMX(R) PSA*
Enzyme Immunoassay, Tracrolimus
FDA Pre-Market Approval
FDA Class 2
·ABBOTT IMX TACROLIMUS II
IMX CMV IGG ANTIBODY ASSAY
FDA 510(k)
FDA Class 2
·Microbiology
ABBOTT IMX(TM) D-DIMER
FDA 510(k)
FDA Class 2
·Hematology